Ashland (ASH) to Divest Nutraceuticals Business to Turnspire
Ashland(ASH) Zacks Investment Research·2024-05-09 16:05Ashland Inc. (ASH) announced an agreement to sell its nutraceuticals business to Turnspire Capital Partners LLC. The deal is anticipated to close during the calendar third quarter of 2024, pending the fulfillment of standard closing conditions.Ashland's nutraceuticals business offers a wide range of active ingredients and formulation aids to nutrition product manufacturers. It also provides custom formulation and contract manufacturing services for the nutrition sector. The business operates from four produ ...